Related Experiment Video
Updated: Jun 21, 2026

13:47
Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery
Published on: June 23, 2011
Design and optimisation of potent gp120-CD4 inhibitors
Thien-Duc Tran1, Fiona M Adam, Frederick Calo
1Discovery Chemistry, Pfizer Global Research and Development, Sandwich Laboratories, Ramsgate Road, Sandwich, Kent, UK. thien.tran@pfizer.com
Bioorganic & Medicinal Chemistry Letters
|July 28, 2009
Abstract:
The synthesis and structure-activity relationship of a series of novel gp120-CD4 inhibitors are described. Pharmacokinetic studies and antiviral spectrum assessment of lead compounds led to the identification of compound 36, a potent gp120-CD4 inhibitor which exhibited antiviral potency across a spectrum of 25 clade B isolates.

